Date published: 2026-4-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

FRAG1 Activators

The chemical class known as FRAG1 Activators comprises a diverse array of compounds that are believed to enhance the expression or activity of FRAG1, a protein integral to various cellular signaling processes. These activators employ multiple mechanisms to exert their influence, reflecting the complexity of cellular regulation and the multifunctional nature of FRAG1. Some activators may directly modulate the transcription of the FRAG1 gene, influencing its expression at the genetic level. Others might work by altering the epigenetic environment surrounding the FRAG1 gene, thereby affecting gene accessibility and expression. This can include changes to DNA methylation patterns or modifications of histones, the proteins around which DNA is wound. Additionally, certain FRAG1 Activators might impact the stability and degradation of the FRAG1 protein itself, for instance, by inhibiting enzymes that tag the protein for degradation. These various modes of action are facilitated by the structural diversity of the activators, which can range from small, synthetically designed molecules to complex, naturally occurring compounds.

Moreover, FRAG1 Activators can interact with upstream signaling pathways that indirectly lead to increased levels of FRAG1. This includes molecules that affect the activity of transcription factors directly regulating the FRAG1 gene or modulate larger signaling networks that consequently enhance FRAG1 expression. The efficacy and mode of action of these activators are highly context-dependent, varying with cell type, the presence of specific cellular receptors or enzymes, and overall cellular environment. This contextual sensitivity underlines the intricacy of cellular signaling networks and the nuanced role of FRAG1 within these networks. The diverse chemical nature of FRAG1 Activators correlates with a broad range of pharmacokinetic and pharmacodynamic properties, shaping how these molecules interact within the cellular milieu and influence FRAG1-related pathways.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

As a DNA methyltransferase inhibitor, it might upregulate FRAG1 by demethylating its promoter region, leading to increased transcription in certain cell types.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

As a histone deacetylase inhibitor, it could upregulate FRAG1 by making the chromatin structure more open and accessible for transcription.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Might upregulate FRAG1 in specific tissues by modulating gene expression through retinoic acid receptors.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

This glucocorticoid might upregulate FRAG1 as part of a cellular response to steroid hormones, especially in tissues sensitive to glucocorticoids.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Could upregulate FRAG1 in estrogen-responsive tissues by modulating estrogen receptor activity.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Might upregulate FRAG1 through its action as a histone deacetylase inhibitor, leading to epigenetic changes that increase gene expression.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Could potentially upregulate FRAG1 through cAMP-dependent pathways by activating adenylate cyclase.